![](/img/cover-not-exists.png)
1192 VAST MAJORITY OF DETECTED NS5A RESISTANT VARIANTS ARE NOT AMPLIFIED IN HCV PATIENTS DURING 3-DAY MONOTHERAPY WITH THE OPTIMIZED NS5A INHIBITOR PPI-668
Huang, Q., Huang, N., Huq, A., Lau, M., Peng, E., Lalezari, J., Farrell, G., Shah, P., Lawitz, E., Vig, P., Brown, N., Colonno, R.Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)61193-9
Date:
April, 2013
File:
PDF, 53 KB
english, 2013